BioIntegrate Report issue

For profit Phase 2
Founded: Lawrenceville Georgia United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04424394
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

BioIntegrate

Active Ingredients

Drugs in Phase 2 Trials (1)

wharton's jelly mesenchymal stem cells (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1